LIGAND PHARMACEUTICALS INCORPORATED Payments for Hedge, Financing Activities
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- LIGAND PHARMACEUTICALS INCORPORATED payments for hedge, financing activities for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED payments for hedge, financing activities for the quarter ending 2022-06-30 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED payments for hedge, financing activities for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED payments for hedge, financing activities for the quarter ending 2021-12-31 was -$18.45M.
- LIGAND PHARMACEUTICALS INCORPORATED payments for hedge, financing activities for fiscal 2021 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED payments for hedge, financing activities for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- LIGAND PHARMACEUTICALS INCORPORATED payments for hedge, financing activities for fiscal 2019 was $12.40M, a 97.18% decline from fiscal 2018.
- LIGAND PHARMACEUTICALS INCORPORATED payments for hedge, financing activities for fiscal 2018 was $439.58M.
| Period end | Payments for Hedge, Financing Activities 3 month | Payments for Hedge, Financing Activities 12 month |
|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$18.45M derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$16.46M derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-09 | -$16.46M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-12-31 | -$18.45M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 |
| 2021-09-30 | $1.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $18.45M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $16.46M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $16.46M 10-Q · filed 2022-05-09 | $16.46M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $12.40M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-06 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $12.40M 10-K · filed 2022-02-28 |
| 2019-09-30 | $12.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | |
| 2018-12-31 | $439.58M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $439.58M 10-K · filed 2021-02-24 |
| 2018-09-30 | -$140.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $0.00 10-K · filed 2020-02-27 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | |
| 2016-12-31 | $0.00 10-K · filed 2019-02-28 |